155.39USD-0.92%Mkt Cap: 9.13B $P/E: —1d ago
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, develops therapies for the treatment of glaucoma, corneal disorders, and retinal diseases in the United States and internationally. It off…
Industry Peers
Medical Devices$172.11BUSDP/E 27.7
$126.97BUSDP/E 38.3
$66.32BUSDP/E 18.7
$50.58BUSDP/E 47.5
$42.77BUSDP/E 18.9
$30.09BUSDP/E 33.5
$29.89BUSDP/E 15.8
$25.20BUSDP/E 23.9
$18.14BUSDP/E 24.3
$14.05BUSDP/E 23.0
$12.57BUSDP/E 73.6
$11.39BUSDP/E 38.4
$10.66BUSDP/E 21.5
$10.98BUSDP/E 18.9
$8.74BUSDP/E 25.4
$9.02BUSD
$8.05BUSDP/E 50.2
$5.50BUSDP/E 24.4
$5.15BUSDP/E 95.3
$3.79BUSD
$3.57BUSDP/E 38.3
$3.18BUSDP/E 31.8
$3.38BUSDP/E 24.7
$2.71BUSDP/E 39.5
$2.63BUSDP/E 17.4
$2.25BUSD
$2.12BUSD
$1.95BUSDP/E 51.0
$1.99BUSDP/E 29.2
$1.75BUSD
$1.79BUSDP/E 10.8
$1.83BUSD
$1.64BUSDP/E 19.9
$1.73BUSD
$1.62BUSD
$1.53BUSDP/E 9.2
$1.54BUSD
$1.45BUSDP/E 24.7
$1.49BUSDP/E 11.7
$1.48BUSD
$1.43BUSD
$1.28BUSDP/E 17.7
$1.29BUSDP/E 135.4
$1.25BUSD
$1.36BUSDP/E 25.4
$1.25BUSDP/E 53.4
$1.25BUSDP/E 102.9
$1.24BUSD
$1.17BUSD
$1.07BUSDP/E 41.6
$1.12BUSD
$1.09BUSD
$1.08BUSD
$935.36MUSDP/E 346.3
$961.77MUSDP/E 17.9
$842.11MUSDP/E 30.3
$777.63MUSDP/E 20.0
$744.00MUSDP/E 34.6
$741.20MUSDP/E 87.2
$785.87MUSD
$753.09MUSD
$726.22MUSD
$663.38MUSDP/E 33.8
$643.18MUSD
$599.22MUSD
$536.61MUSDP/E 40.5
$561.52MUSD
$523.46MUSD
$480.61MUSD
$463.49MUSDP/E 32.7
$462.80MUSD
$453.50MUSD
$451.64MUSD
$443.60MUSDP/E 1285.0
$393.08MUSDP/E 26.9
$402.22MUSDP/E 21.6
$393.41MUSD
$373.19MUSD
$399.65MUSD
$354.39MUSDP/E 36.6
$311.65MUSDP/E 24.3
$336.44MUSD
$335.68MUSD
$319.27MUSD
$304.01MUSD
$287.39MUSD
$269.90MUSDP/E 29.5
$282.93MUSD
$264.26MUSD
$268.32MUSD
$267.78MUSD
$230.91MUSDP/E 44.9
$228.36MUSD
$230.58MUSD
$193.63MUSD
$186.54MUSD
$186.48MUSDP/E 25.0
$182.76MUSD
$171.22MUSD
$180.32MUSD
$178.41MUSD
$168.28MUSD
$153.27MUSD
$144.61MUSD
$143.03MUSD
$120.82MUSD
$118.33MUSDP/E Infinity
$123.87MUSD
$112.94MUSDP/E 40.7
$105.74MUSD
$95.59MUSD
$104.13MUSD
$97.49MUSD
$85.33MUSD
$86.15MUSD
$78.56MUSDP/E 124.9
$80.82MUSD
$74.59MUSD
$68.69MUSD
$69.64MUSD
$59.10MUSD
$62.14MUSDP/E 44.3
$61.24MUSD
$55.20MUSD
$53.97MUSD
$58.54MUSD
$53.47MUSD
$51.92MUSD
$52.51MUSD
$51.22MUSD
$49.63MUSD
$46.44MUSDP/E 15.6
$48.19MUSD
$47.95MUSD
$42.86MUSD
$43.10MUSD
$39.38MUSD
$42.00MUSD
$37.53MUSD
$40.57MUSD
$39.88MUSDP/E 37.6
$34.43MUSD
$30.99MUSD
$33.60MUSD
$33.46MUSD
$30.06MUSD
$31.56MUSD
$28.62MUSD
$28.33MUSD
$27.79MUSD
$24.79MUSD
$23.21MUSD
$20.81MUSD
$20.27MUSD
$20.63MUSD
$18.03MUSD
$17.06MUSD
$16.53MUSDP/E Infinity
$16.06MUSD
$16.55MUSD
$16.43MUSD
$13.93MUSD
$13.24MUSD
$15.03MUSD
$13.52MUSD
$13.97MUSD
$13.36MUSD
$11.72MUSDP/E 34.2
$13.14MUSD
$11.28MUSD
$11.77MUSD
$10.03MUSD
$9.69MUSD
$9.94MUSD
$9.79MUSD
$8.80MUSD
$9.09MUSD
$9.02MUSD
$6.85MUSD
$6.39MUSD
$5.95MUSD
$6.49MUSD
$5.74MUSD
$5.07MUSD
$5.26MUSD
$5.04MUSD
$4.53MUSD
$4.00MUSD
$3.44MUSD
$2.86MUSD
$2.67MUSD
$2.65MUSD
$2.45MUSD
$2.31MUSD
$2.02MUSDP/E 0.0
$1.76MUSD
$1.38MUSD
$1.30MUSD
$1.35MUSD
$985.8KUSD
$529.9KUSD
$376.3KUSD
$271.1KUSD
$41.9KUSD
$17.8KUSD
$4.0KUSD
$3.0KUSD
$2.1KUSD
$1.6KUSD
$887USD
$638USD
—
Indicators:|
| Headline | Source | Time |
|---|---|---|
This week | ||
Glaukos CFO Alex Thurman Sells $1.6 Million in Stock. What Should Investors Do Now? Disposition represented 19% of insider's equity holdings under pre-established Rule 10b5-1 trading plan. Thurman retains 43,681 shares worth approximately $6.77 million. | ||
Older | ||